India is increasingly becoming a preferred destination for the global pharmaceutical supply chain, according to a recent report by Macquarie. The country’s strong manufacturing capabilities, cost efficiency, and regulatory reforms are driving its growth in the sector.
The report highlights that India’s pharmaceutical industry, already valued at over $50 billion, is poised for further expansion as global companies seek to reduce dependence on China. With a well-established ecosystem of raw material suppliers, skilled workforce, and world-class production facilities, India offers a competitive edge in active pharmaceutical ingredients (APIs) and generic medicines.
Government initiatives such as the Production-Linked Incentive (PLI) scheme and policy support for domestic API production have further strengthened India’s position. Additionally, rising investments in research and development (R&D) and the adoption of advanced technologies, including AI-driven drug discovery and digital healthcare solutions, are making India an attractive hub for global pharma giants.
With increasing partnerships, export growth, and a favorable policy landscape, India is set to play a crucial role in ensuring a resilient and diversified global pharmaceutical supply chain. As multinational firms continue to shift their sourcing strategies, India stands out as a key beneficiary of this transformation.
#PharmaceuticalIndustry #IndiaPharma #GlobalSupplyChain #APIs #DrugManufacturing #HealthcareInnovation #MedTech #PharmaGrowth #MakeInIndia #PLI #HealthcareStartups #DigitalHealth #Biopharma #R&D #AIinHealthcare #PharmaExports #SupplyChainResilience #HealthcareTech #Dseidehealthcarenetwork
Source: Financial Express
The report highlights that India’s pharmaceutical industry, already valued at over $50 billion, is poised for further expansion as global companies seek to reduce dependence on China. With a well-established ecosystem of raw material suppliers, skilled workforce, and world-class production facilities, India offers a competitive edge in active pharmaceutical ingredients (APIs) and generic medicines.
Government initiatives such as the Production-Linked Incentive (PLI) scheme and policy support for domestic API production have further strengthened India’s position. Additionally, rising investments in research and development (R&D) and the adoption of advanced technologies, including AI-driven drug discovery and digital healthcare solutions, are making India an attractive hub for global pharma giants.
With increasing partnerships, export growth, and a favorable policy landscape, India is set to play a crucial role in ensuring a resilient and diversified global pharmaceutical supply chain. As multinational firms continue to shift their sourcing strategies, India stands out as a key beneficiary of this transformation.
#PharmaceuticalIndustry #IndiaPharma #GlobalSupplyChain #APIs #DrugManufacturing #HealthcareInnovation #MedTech #PharmaGrowth #MakeInIndia #PLI #HealthcareStartups #DigitalHealth #Biopharma #R&D #AIinHealthcare #PharmaExports #SupplyChainResilience #HealthcareTech #Dseidehealthcarenetwork
Source: Financial Express
India is increasingly becoming a preferred destination for the global pharmaceutical supply chain, according to a recent report by Macquarie. The country’s strong manufacturing capabilities, cost efficiency, and regulatory reforms are driving its growth in the sector.
The report highlights that India’s pharmaceutical industry, already valued at over $50 billion, is poised for further expansion as global companies seek to reduce dependence on China. With a well-established ecosystem of raw material suppliers, skilled workforce, and world-class production facilities, India offers a competitive edge in active pharmaceutical ingredients (APIs) and generic medicines.
Government initiatives such as the Production-Linked Incentive (PLI) scheme and policy support for domestic API production have further strengthened India’s position. Additionally, rising investments in research and development (R&D) and the adoption of advanced technologies, including AI-driven drug discovery and digital healthcare solutions, are making India an attractive hub for global pharma giants.
With increasing partnerships, export growth, and a favorable policy landscape, India is set to play a crucial role in ensuring a resilient and diversified global pharmaceutical supply chain. As multinational firms continue to shift their sourcing strategies, India stands out as a key beneficiary of this transformation.
#PharmaceuticalIndustry #IndiaPharma #GlobalSupplyChain #APIs #DrugManufacturing #HealthcareInnovation #MedTech #PharmaGrowth #MakeInIndia #PLI #HealthcareStartups #DigitalHealth #Biopharma #R&D #AIinHealthcare #PharmaExports #SupplyChainResilience #HealthcareTech #Dseidehealthcarenetwork
Source: Financial Express
